Literature DB >> 30124795

Trajectory assessment is useful when day-to-day esophageal acid exposure varies in prolonged wireless pH monitoring.

R Yadlapati1, J D Ciolino2, J Craft3, S Roman4, J E Pandolfino5.   

Abstract

Acid exposure time commonly varies from day-to-day in prolonged wireless pH monitoring. Thus, diagnosis based on the number of days with abnormal acid burden may be misleading or inconclusive. We hypothesize that assessing longitudinal patterns of acid exposure may be diagnostically useful. Therefore, this study aims to describe acid exposure trajectories and evaluate agreement between identified trajectory patterns and conventional grouping. In this retrospective cohort study, we assessed patients with nonresponse to proton pump inhibitor therapy who underwent wireless pH monitoring (≥72 h) off therapy between August 2010 and September 2016. The primary outcome was esophageal acid exposure time. Subjects were grouped as 0, 1, 2, and 3+ days positive based on number of days with an acid exposure time >5.0%. Latent class group-based mixture model identified distinct longitudinal acid exposure trajectory groups. Of 212 subjects included 44%, 18%, 14%, and 24% had 0, 1, 2, 3+ days positive, respectively. Group-based modeling identified three significantly stable acid exposure trajectories: low (64%), middle (28%), and high (8%). Trajectory grouping and days positive grouping agreed substantially (weighted K 0.69; 95% CI: 0.63-0.76). Trajectory grouping identified 62% of subjects with conventionally inconclusive studies (one or two days positive) into the low trajectory. Agreement between trajectory groups when using three versus four days of monitoring was substantial (K 0.70; CI: 0.61-0.78). In summary, we found that patients with nonresponse to proton pump inhibitors follow three acid exposure trajectories over prolonged pH-monitoring periods: low, middle, and high. Compared to conventional day positive grouping, the trajectory modeling identified the majority of inconclusive days positive into the low trajectory group. Analyzing prolonged wireless pH data according to trajectories may be a complimentary method to conventional grouping, and may increase precision and accuracy in identifying acid burden.
© The Author(s) 2018. Published by Oxford University Press on behalf of International Society for Diseases of the Esophagus.

Entities:  

Keywords:  Bravo; gastroesophageal reflux disease; proton pump inhibitor nonresponder; reflux monitoring

Mesh:

Substances:

Year:  2019        PMID: 30124795      PMCID: PMC6403452          DOI: 10.1093/dote/doy077

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  24 in total

1.  Prolonged wireless pH monitoring: importance of how to analyse oesophageal acid exposure.

Authors:  Ausilia Grigolon; Ivana Bravi; Piergiorgio Duca; Delia Pugliese; Roberto Penagini
Journal:  Scand J Gastroenterol       Date:  2010-09       Impact factor: 2.423

2.  Wireless oesophageal pH monitoring: feasibility, safety and normal values in healthy subjects.

Authors:  Jörgen Wenner; Folke Johnsson; Jan Johansson; Stefan Oberg
Journal:  Scand J Gastroenterol       Date:  2005-07       Impact factor: 2.423

3.  American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease.

Authors:  Peter J Kahrilas; Nicholas J Shaheen; Michael F Vaezi; Stephen W Hiltz; Edgar Black; Irvin M Modlin; Steve P Johnson; John Allen; Joel V Brill
Journal:  Gastroenterology       Date:  2008-10       Impact factor: 22.682

Review 4.  Use and utility of the Bravo pH capsule.

Authors:  John E Pandolfino; Monika A Kwiatek
Journal:  J Clin Gastroenterol       Date:  2008 May-Jun       Impact factor: 3.062

5.  Day-to-day variability in acid reflux patterns using the BRAVO pH monitoring system.

Authors:  Sushil K Ahlawat; David J Novak; Dionne C Williams; Kathleen A Maher; Franca Barton; Stanley B Benjamin
Journal:  J Clin Gastroenterol       Date:  2006-01       Impact factor: 3.062

6.  Four-day Bravo pH capsule monitoring with and without proton pump inhibitor therapy.

Authors:  Ikuo Hirano; Qing Zhang; John E Pandolfino; Peter J Kahrilas
Journal:  Clin Gastroenterol Hepatol       Date:  2005-11       Impact factor: 11.382

7.  Value of extended recording time with wireless pH monitoring in evaluating gastroesophageal reflux disease.

Authors:  Chandra Prakash; Ray E Clouse
Journal:  Clin Gastroenterol Hepatol       Date:  2005-04       Impact factor: 11.382

8.  Ambulatory esophageal pH monitoring using a wireless system.

Authors:  John E Pandolfino; Joel E Richter; Tina Ours; Jason M Guardino; Jennifer Chapman; Peter J Kahrilas
Journal:  Am J Gastroenterol       Date:  2003-04       Impact factor: 10.864

9.  The impact of prolonged pH measurements on the diagnosis of gastroesophageal reflux disease: 4-day wireless pH studies.

Authors:  Giuseppe Scarpulla; Salvatore Camilleri; Pietro Galante; Miohele Manganaro; Mark Fox
Journal:  Am J Gastroenterol       Date:  2007-09-10       Impact factor: 10.864

10.  Bravo catheter-free pH monitoring: normal values, concordance, optimal diagnostic thresholds, and accuracy.

Authors:  Shahin Ayazi; John C Lipham; Giuseppe Portale; Christian G Peyre; Christopher G Streets; Jessica M Leers; Steven R Demeester; Farzaneh Banki; Linda S Chan; Jeffrey A Hagen; Tom R Demeester
Journal:  Clin Gastroenterol Hepatol       Date:  2008-08-16       Impact factor: 11.382

View more
  4 in total

1.  Prolonged Wireless pH Monitoring in Patients With Persistent Reflux Symptoms Despite Proton Pump Inhibitor Therapy.

Authors:  Stephen Hasak; Rena Yadlapati; Osama Altayar; Rami Sweis; Emily Tucker; Kevin Knowles; Mark Fox; John Pandolfino; C Prakash Gyawali
Journal:  Clin Gastroenterol Hepatol       Date:  2020-01-31       Impact factor: 11.382

2.  Optimal Wireless Reflux Monitoring Metrics to Predict Discontinuation of Proton Pump Inhibitor Therapy.

Authors:  Rena Yadlapati; C Prakash Gyawali; Melina Masihi; Dustin A Carlson; Peter J Kahrilas; Billy Darren Nix; Anand Jain; Joseph R Triggs; Michael F Vaezi; Leila Kia; Alexander Kaizer; John E Pandolfino
Journal:  Am J Gastroenterol       Date:  2022-06-10       Impact factor: 12.045

Review 3.  Factors that Impact Day-to-Day Esophageal Acid Reflux Variability and Its Diagnostic Significance for Gastroesophageal Reflux Disease.

Authors:  Steven D Ma; Vandan Patel; Rena Yadlapati
Journal:  Dig Dis Sci       Date:  2022-04-19       Impact factor: 3.487

4.  Esophageal hypervigilance is prevalent across gastroesophageal reflux disease presentations.

Authors:  Livia Guadagnoli; Rena Yadlapati; Tiffany Taft; John E Pandolfino; Michael Tye; Laurie Keefer
Journal:  Neurogastroenterol Motil       Date:  2021-01-11       Impact factor: 3.960

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.